← FDA Drug Approvals (Drugs@FDA)

LITHIUM CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PAI HOLDINGS PHARM · Approved 1986-05-21

Drug application

FDA Application #

ANDA070755

Application type

Abbreviated New Drug Application (Generic)

Brand name

LITHIUM CITRATE

Generic name

LITHIUM

Active ingredients

LITHIUM CITRATE

Dosage form

SYRUP

Route

ORAL

Marketing status

Prescription

Sponsor

PAI HOLDINGS PHARM

Manufacturer

PAI Holdings, LLC dba PAI Pharma

First approval

1986-05-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown